Evolution of Small Cell Lung Cancer Therapy: Chemotherapy and Beyond

Overview

This program will provide an update of current standards of therapy for first- and second line treatment of extensive-stage small cell lung cancer (SCLC). Management of limited-stage disease will also be discussed.  Indications for radiotherapy in the management of limited and extensive stage patients will be addressed. In addition, new directions in SCLC treatment, including immunotherapy and emerging targeted therapy approaches will be presented.  Discussion will also focus on potential biomarkers to direct therapy in SCLC.

Date
Dec 06, 2017 -
Dec 06, 2017
Location

Online

After viewing this webinar, attendees will:

  • Recognize current treatment standards for limited and extensive stage SCLC;
  • Identify new immunotherapy and targeted-therapy approaches; and
  • Indicate ongoing and planned clinical trials that will impact patient care in the near future.

Suresh S. Ramalingam, MD
Professor of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute.

Charles Rudin, MD, PhD
Chief, Thoracic Oncology Service, Sylvia Hassenfeld Chair in Lung Cancer Research, Co-Director, Drukenmiller Center, for Lung Cancer Research, Professor of Medicine, WCMC, Memorial Sloan Kettering Cancer Center.

For any inquiries, please contact [email protected].

After viewing this webinar, attendees will:

  • Recognize current treatment standards for limited and extensive stage SCLC;
  • Identify new immunotherapy and targeted-therapy approaches; and
  • Indicate ongoing and planned clinical trials that will impact patient care in the near future.

Suresh S. Ramalingam, MD
Professor of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute.

Charles Rudin, MD, PhD
Chief, Thoracic Oncology Service, Sylvia Hassenfeld Chair in Lung Cancer Research, Co-Director, Drukenmiller Center, for Lung Cancer Research, Professor of Medicine, WCMC, Memorial Sloan Kettering Cancer Center.

For any inquiries, please contact [email protected].

Share

Interested in advertising and exhibit opportunities?